Decoy Therapeutics is trading 10.34% up at $3.20, versus the August 28 close of $2.90, with no clear company-specific catalyst identified.

  • No clear company-specific announcement, earnings release, filing, or other catalyst dated August 31, 2026, was identified in reliable coverage.
  • The August 3 intellectual-property expansion and August 12 quarterly results appear stale; broader futures are modestly lower, providing no clear market-wide explanation.